CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-02 | STALNECKER SUSAN M Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-06-02 | NOHRA GUY P Director | Option exercise | +26,493 | 126,610 | ||
| 2025-06-02 | NOHRA GUY P Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-06-02 | NEELS GUIDO J Director | Option exercise | +26,493 | 85,241 | ||
| 2025-06-02 | NEELS GUIDO J Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-06-02 | McMurry-Heath Michelle Director | Option exercise | +26,493 | 74,698 | ||
| 2025-06-02 | McMurry-Heath Michelle Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-06-02 | Ladone Mary Kay Director | Option exercise | +26,493 | 78,981 | ||
| 2025-06-02 | Ladone Mary Kay Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-06-02 | HAWKINS WILLIAM A Director | Option exercise | +26,493 | 257,851 | ||
| 2025-06-02 | HAWKINS WILLIAM A Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-06-02 | Beyer Pat Director | Option exercise | +26,493 | 76,436 | ||
| 2025-06-02 | Beyer Pat Director | Option exercise · Restricted Stock Units | −26,493 | 0 | ||
| 2025-04-11 | Singleton Mark Leonard SVP & CFO | Sale 10b5-1 | −3,875 | $7.57 | $29K | 141,088 |
| 2025-04-11 | D'Adamio Anthony SVP & General Counsel | Sale 10b5-1 | −2,958 | $7.57 | $22K | 131,416 |
| 2025-04-11 | CHURCH KATRINA J SVP & Chief Compliance Officer | Sale 10b5-1 | −1,283 | $7.57 | $10K | 55,557 |
| 2025-04-10 | Singleton Mark Leonard SVP & CFO | Option exercise | +13,000 | 144,963 | ||
| 2025-04-10 | Singleton Mark Leonard SVP & CFO | Option exercise · Restricted Stock Units | −13,000 | 26,000 | ||
| 2025-04-10 | D'Adamio Anthony SVP & General Counsel | Option exercise | +9,925 | 134,374 | ||
| 2025-04-10 | D'Adamio Anthony SVP & General Counsel | Option exercise · Restricted Stock Units | −9,925 | 19,850 |
Page 6 of 22 · 437 trades